Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Mother’s gut microbiota strengthens newborn's immunity

No. 15c | 18/03/2016 | by Koh

Already during pregnancy, microbes in the mother’s gut shape the baby's immune system. This effect is brought about by microbial molecules that are transmitted to the baby across the placenta or via antibodies in the mother's milk. Scientists from Bern University Hospital, the University of Bern, the German Cancer Research Center (DKFZ) and ETH Zurich have now reported this finding in an article published in Science.

© Rocky Mountain Laboratories, NIAID, NIH [Public domain], via Wikimedia Commons

Babies are born with immature immune systems. Up until now, scientists have assumed that newborns start after birth to adapt to the host of microorganisms that compose their own intestinal microbiome. In experiments with mice, scientists from Bern University Hospital, the University of Bern, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and ETH Zurich have now discovered that the mother's gut microbiota prepares the baby already in the womb for the process of microbial colonization that takes place after birth. The gut research group at the University Hospital of Bern (Inselspital) has been pursuing basic and clinical research in this field for many years and ranges among the world's most renowned research teams. Mathias Heikenwälder from the DKFZ and his group supported their Swiss colleagues by conducting an analysis of the immune system, particularly of the secondary lymphatic organs, during this phase in immune development.

Microbial invasion after birth

When a baby is born, it leaves the sterile, sheltered environment of the uterus and enters a world that teems with microbes. After birth, microorganisms quickly colonize all surfaces of the body. Within a few days, the intestine is inhabited by ten times more microbes than there are cells in the baby's whole body.

Newborns normally survive this sudden invasion of bacteria without problems. However, more than six million infants under the age of five still die worldwide each year, most of them as a result of intestinal infections or malnutrition. The critical challenge after birth is that trillions of microbes must colonize the intestine without infecting the newborn, provoking a strong immune response or impeding the gut's capacity to absorb nutrients.

Harmless molecules from the gut

In their current article, the researchers report that molecules of microbes living in the maternal intestine can enter the mother's body and then get transmitted to the baby via the placenta or, after birth, during breast feeding via antibodies that are contained in the mother's milk. These microbial fragments are harmless and do not cause any infection. Instead, they stimulate cells in the baby's body to prepare its immune system and gut for the time after birth when the newborn has to cope with the microorganisms living in its own intestine.

“For this work, we studied bacteria that do not cause disease,” says Heikenwälder. “But our results most likely also hold true for dangerous pathogens, against which the newborn can produce a better defense thanks to this preparation of the immune system.” Andrew Macpherson, Research Director at Bern University Hospital, added: “We have always known that we may be grateful to our mothers for their love and protection, now we know that we should also be grateful to them for their gut microbiota.”

Mercedes Gomez de Agüero, Stephanie C. Ganal-Vonarburg, Tobias Fuhrer, Sandra Rupp, Yasuhiro Uchimura, Hai Li, Anna Steinert, Mathias Heikenwälder, Siegfried Hapfelmeier, Uwe Sauer, Kathy D. McCoy, Andrew J. Macpherson: The maternal microbiota drives early postnatal innate immune development: Science 2016, DOI: 10.1126/science.aad2571

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

RSS-Feed

Subscribe to our RSS-Feed.

to top
powered by webEdition CMS